LOADING
Comparing Pfizer Inc (PFE) and AT&T Inc (T) across the Health Care and Communication Services sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | PFE | T |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | $160.0B | $173.3B |
| P/E Ratio | 36.5 | 8.3 |
| Forward P/E | 9.4 | 10.8 |
| PEG Ratio | 2.69 | 1.67 |
| EPS | $0.77 | $3.05 |
| Revenue Growth (YoY) | 2.6% | 2.3% |
| Profit Margin | 6.8% | 16.9% |
| Return on Equity | 5.0% | 18.3% |
| Dividend Yield | 6.19% | 4.41% |
| Beta | 0.28 | 0.42 |
| 52-Week High | $28.44 | $28.75 |
| 52-Week Low | $22.03 | $19.63 |
| Volume | -- | -- |
AT&T Inc is the larger company by market capitalization. AT&T Inc trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Pfizer Inc offers a higher dividend yield for income investors. AT&T Inc has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.